We apply the highest scientific rigor to our work and share learnings to advance science that can benefit society. As a result, our scientists and their work are frequently published in peer-reviewed journals. Review a selection of our publications.
为科学界做出贡献
Recent publications
| Title | Author | 出版物 | 日期 |
| Venetoclax增加了肿瘤内效应T细胞和抗肿瘤功效，并结合免疫检查点阻滞 | Kohlhapp et al. | 癌症发现 | 2021 |
| Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues | Naseri Kouzehgarani等。 | 高级药物输送评论 | 2021 |
| Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease | Rosenbraugh等。 | Annals of Neurology | 2021 |
| High-Throughput Label-Free Biochemical Assays Using Infrared Matrix-Assisted Desorption Electrospray Ionization Mass Spectrometry | Pu et al. | 分析化学 | 2021 |
| Optimized Culture Conditions for Improved Growth and Functional Differentiation of Mouse and Human Colon Organoids | Wilson et al. | 免疫学领域 | 2021 |
| 在小鼠间质脑液中收集抗体和大分子生物标志物：微透析和脑开放流微灌注的比较 | Le Prieult等。 | MAbs | 2021 |
| 使用Elagolix 3期钙稳态的定量系统药理学模型验证子宫内膜异位女性的临床试验数据 | Stodtman等。 | Clinical Translational Science | 2021 |
以前的出版物
| Title | Author | 出版物 | 日期 |
| Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer | Faivre等。 | Nature | 2020 |
| 免疫刺激和抑制微环境之间的平衡评分确定了肿瘤免疫的介质，并预测了泛癌的存活率 | Turan等。 | British Journal of Cancer | 2020 |
| Epitope and Fc-mediated cross-linking, but not high affinity, are critical for antitumor activity of CD137 agonist antibody with reduced liver toxicity | Ho等。 | 分子癌治疗剂 | 2020 |
| 副磷脂I可以用作OATP1B1抑制的内源性生物标志物：使用Glecaprevir/pibrentasvir临床研究评估 | Kalluri等。 | Clinical Translational Science | 2020 |
| 基于蛋白质和网络特性的肿瘤药物目标的机器学习预测 | Dezso等。 | BMC Bioinformatics | 2020 |
| Evaluation of Tissue Stem Cell–Derived Human Intestinal Organoids, a Physiologically Relevant Model to Evaluate Cytochrome P450 Induction in Gut | 压力师等。 | 药物代谢和性格 | 2020 |
| Use of Zebrafish in Drug Discovery Toxicology | Cassar等。 | 毒理学化学研究 | 2019 |
